University Of Texas At Dallas

University Of Texas At Dallas, a public research institution and child entity of the University of Texas System, operates as a prime recipient of federal research grants and a subcontractor to industry primes, competing predominantly in unrestricted full-and-open federal research funding across 129 customer agencies. The institution has received 1,737 federal awards (87% prime, 13% sub) totaling $1.22 billion obligated against $115.4 million in combined potential value—a signature profile of long-term, renewable grant funding characteristic of research universities rather than discrete procurements.

UTD's federal footprint is concentrated in research and development across space science, materials engineering, quantum computing, biomedical sciences, and artificial intelligence. Recent representative prime awards include a $4.741 million Missile Defense Agency definitive contract for two-photon absorption laser system enhancements (cost-reimbursable, no fee); a $2.885 million NASA Goddard Space Center thermal plasma sensor development contract for stand-alone space flight investigations; and a $1.928 million National Institute of General Medical Sciences grant investigating cellular metabolism in embryonic development. Grant activity dominates: the National Science Foundation accounts for 472 awards across multiple divisions (Computer and Network Systems, Electrical/Communications/Cyber Systems, Atmospheric and Geospace Sciences, Engineering, and others), while NASA's Shared Services Center has placed 98 awards ($23.7 million combined value) funding balanced science programs aligned with space exploration and atmospheric monitoring. The National Institutes of Health, through multiple institutes including the National Institute of Neurological Disorders and Stroke, funds biomedical research spanning neuroscience, infectious diseases, aging, and chronic pain mechanisms. Recent NIH awards illustrate scope: a $4.04 million National Institute of Neurological Disorders and Stroke grant for pain therapeutic target identification using human dorsal root ganglion neurons; a $828 thousand National Institute of General Medical Sciences award on cellular metabolism and embryonic development; a $641 thousand National Heart, Lung, and Blood Institute grant on gut microbiome targets for sickle cell disease pain management.

Customer concentration is moderate across the top funders—NSF alone represents approximately 27% of recent awards by count, while NASA's Shared Services Center leads dollar volume at $23.7 million. The Air Force Materiel Command Research Laboratory, Defense Advanced Research Projects Agency, and Department of the Navy's Office of Naval Research provide additional defense and space-focused funding. Within the last 24 months, 162 awards (combined potential value $11.4 million) approach completion and represent immediate recompete exposure.

UTD's vehicle position reflects its status as a research institution: the institution holds an Other Transaction IDV from the Defense Advanced Research Projects Agency ($1 million ceiling, awarded November 2024) for materials investigation and atomic oxygen resistant coatings development. The institution places minimal work against traditional GSA Schedules or government-wide acquisition contracts, instead competing directly under federal grant mechanisms (NSF, NIH, DOE, DOD) and single-agency IDVs. The Federal Supply Schedule GS10F0267U appears minimally leveraged ($6.7 million across one task order), indicating UTD does not maintain a significant position in federal contracting vehicles typical of commercial federal contractors.

UTD subcontracts primarily to defense primes—Northrop Grumman Systems Corporation, Booz Allen Hamilton, Leidos, and others—on specialized technical work including heat removal in electronics at device scale (THREADS program), cloud engineering for modernization initiatives, and cyber operations support. Sub-recipient roles with peer research institutions (University of Texas Southwestern Medical Center, Mayo Clinic, University of Maryland, University of Pennsylvania) characterize collaborative grant performance, particularly in NIH-funded biomedical research where UTD contributes specialized neurophysiology labs, imaging analysis, and computational modeling expertise.

The institution's award trajectory shows growth through 2024 (165 awards) with contraction in 2025 and 2026 (148 and 85 awards respectively, likely reflecting data lag in the source). The institution competes on merit without SBA set-aside designations—all recent awards examined carry "No Set-Aside Used" language, reflecting the full-and-open competitive research funding environment in which public universities operate.

Research strengths evident from the award portfolio span space physics and magnetosphere studies (energetic particle precipitation, ionospheric monitoring, cubesat mission design); advanced materials and semiconductor engineering (amorphous oxide semiconductors for 3D circuits, perovskite thin films, metasurface optimization); quantum computing and neuromorphic systems; biomedical engineering (tissue engineering, biosensors, medical imaging); and artificial intelligence security and autonomous systems. Federal stakeholder relationships with DARPA, NSF multiple directorates, NIH institutes, NASA, and the Department of Energy position UTD as a versatile research partner in federal STEM investment. The institution's Richardson, Texas campus serves as the primary performance location across nearly all awards, supporting a substantial research workforce in computational science, materials characterization, and biomedical research.